FDA — authorised 7 December 2012
- Application: NDA204200
- Marketing authorisation holder: PH HEALTH
- Status: supplemented
🇺🇸 adrenalin in United States
FDA authorised adrenalin on 7 December 2012
Marketing authorisations
FDA — authorised 18 December 2013
- Application: NDA204640
- Marketing authorisation holder: PH HEALTH
- Status: supplemented
FDA — authorised 21 April 2023
- Application: NDA215875
- Marketing authorisation holder: PH HEALTH
- Status: supplemented
FDA
- Status: approved
Other Nephrology approved in United States
Frequently asked questions
Is adrenalin approved in United States?
Yes. FDA authorised it on 7 December 2012; FDA authorised it on 18 December 2013; FDA authorised it on 21 April 2023.
Who is the marketing authorisation holder for adrenalin in United States?
PH HEALTH holds the US marketing authorisation.